CRISPR/Cas9 mutagenesis invalidates a putative cancer dependency targeted in on-going clinical trials (Q42108657)

From Wikidata
Jump to navigation Jump to search
scientific article published on 24 March 2017
edit
Language Label Description Also known as
English
CRISPR/Cas9 mutagenesis invalidates a putative cancer dependency targeted in on-going clinical trials
scientific article published on 24 March 2017

    Statements

    CRISPR/Cas9 mutagenesis invalidates a putative cancer dependency targeted in on-going clinical trials (English)
    0 references
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit